GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
138 hedge funds and large institutions have $2.41B invested in GW Pharmaceuticals Plc American Depositary Shares in 2016 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 19 closing their positions.
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
116% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 19
75% more capital invested
Capital invested by funds: $1.38B → $2.41B (+$1.03B)
19% more funds holding
Funds holding: 116 → 138 (+22)
18% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 34
10% more call options, than puts
Call options by funds: $262M | Put options by funds: $237M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$52.2M |
| 2 |
SCM
Scopia Capital Management
New York
|
+$38.9M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$37.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$36.3M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$30.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$20.4M |
| 2 |
Bank of New York Mellon
New York
|
-$16M |
| 3 |
FHAM
Folger Hill Asset Management
New York
|
-$14M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$8.32M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$6.89M |
GWPH Hedge Fund Activity: Q3 2016 in Review
138 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2016, worth a combined $2.41B — up 75% from $1.38B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new GWPH positions and 19 closed out — a net gain of 22 holders — while 40 added to existing stakes and 34 trimmed.
The largest buyer was Redmile Group, opening a new position worth an estimated $52.2M. The largest seller was Federated Hermes, cutting an estimated $20.4M.
- 138 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2016, up from 116 in Q2 2016.
- Funds reported $2.41B of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2016, up 75% quarter-over-quarter.
- 41 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2016 and 19 closed out, a net change of +22 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2016 was Redmile Group, an estimated $52.2M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2016 was Federated Hermes, an estimated $20.4M sold.
Based on aggregated 13F filings for Q3 2016.